'Adverse event' won't halt Oxford vaccine trial: Health Ministry

The initial findings into an 'adverse event' allegedly suffered by an Oxford COVID-19 vaccine trial participant in Chennai did not necessitate halting of the trials, the Centre said on Tuesday while clarifying that the 'adverse event' will not affect the timelines of vaccine rollout in any manner. The Union Health Ministry further said that the 'adverse event' during the Serum Institute of India (SII) trial was being reviewed by the Drugs Controller General of India (DCGI) to ascertain if there is any causal link between the event and the shot administered to him.

The initial findings into an 'adverse event' allegedly suffered by an Oxford COVID-19 vaccine trial participant in Chennai did not necessitate halting of the trials, the Centre said on Tuesday while clarifying that the 'adverse event' will not affect the timelines of vaccine rollout in any manner. The Union Health Ministry further said that the 'adverse event' during the Serum Institute of India (SII) trial was being reviewed by the Drugs Controller General of India (DCGI) to ascertain if there is any causal link between the event and the shot administered to him. December 02, 2020 at 09:39AM https://ift.tt/36sVWlc